Solentim’s integrated ‘ECOSYSTEM’ for Cell Line Development: New Poster

Cell line development tracks the journey of individual high value cells from clonality through growth, selection and ultimately banking. Decisions made at each step require information from different technologies, traditionally disparate and unconnected platforms but now, in Solentim’s new ecosystem, data is united under one managed process. Solentim instruments each generates insightful, high-quality data to …

Read more Solentim’s integrated ‘ECOSYSTEM’ for Cell Line Development: New Poster

SLAS new product award banner image

Solentim wins New Product Award at SLAS 2021

Bournemouth, UK, 29th January 2021 / Solentim is delighted to have won a New Product Award from the Society for Laboratory Automation and Screening (SLAS), announced this week at SLAS Digital 2021. Solentim achieved this award with the launch of its new ICON™ and STUDIUS™ technologies. ICON is the world’s first benchtop system for characterizing high …

Read more Solentim wins New Product Award at SLAS 2021

VIPS™ unlocks the concept of the one plate project with high efficiency seeding for 384 well plates.

Solentim’s VIPS high efficiency single cell seeder now supports 384 well plate seeding. Confirmation of seeding is backed with the true ‘double lock’ of assurance using confirmation of the single cell in the well post dispensing followed by Day0 whole-well imaging. With VIPS low pressure seeding and the environment of the 384 well, even higher …

Read more VIPS™ unlocks the concept of the one plate project with high efficiency seeding for 384 well plates.

Redefining cell line development

Following the launch of Solentim’s new ICON™ instrument and dedicated STUDIUS™ software, the two of which complete the company’s cutting-edge ecosystem, we spoke with Dr Ian Taylor, Chief Business Officer, Solentim, to find out what this means for cell line development and the future of antibody therapeutics.

Read more Redefining cell line development

ICON

Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

Bournemouth, UK, 25th January 2021 / Solentim, the trusted global leader in cell therapy workflows enabling the creation, isolation and characterization of high value cells, is delighted to launch two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is a proprietary …

Read more Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy

Philip D. Manos, Founder and President of EverCell Bio, Natick, Massachusetts, USA “Our mission is to accelerate the implementation of human and disease-specific stem cell technologies for drug discovery and personalized medicine” EverCell Bio is a single-source provider of customized services for the application of stem cell technology in cell therapy. EverCell offers human cell-modelling …

Read more Why Evercell Bio chose VIPS: a new workflow for hiPSC in cell therapy